Accreditation must for hospitals in State Insurance Scheme

Source: The Hindu

In an attempt to establish standards of care for patients and safety in healthcare institutions in Tamil Nadu, the Chief Minister’s Comprehensive Health Insurance Scheme (CMCHIS) is contemplating making accreditation mandatory for hospitals seeking empanelment as part of the scheme.

A couple of protocols, pre-accreditation entry-level standards for hospitals and the other for smaller healthcare organisations have already been readied and issued as a circular, besides being hosted on the CMCHIS website.

“The idea is that even if the patients are not paying for the treatment, the government is. It is not charity that the hospitals are doing, and patients need to get the best,” a Health Department official said.

This is seen as the first move to bring both private and public healthcare institutions within the ambit of quality regulation, something that is achieved merely by self-motivation currently.

The standards have been evolved in consultation with the National Accreditation Board for Hospitals (NABH), and are in fact inspired by their entry-level accreditation standards that make it easier for hospitals to imbibe quality control culture.

“Earlier, hospitals which could not afford the process of quality control would just stay away. But, we are now offering them a foot in the door,” K.K. Kalra, CEO, NABH, had told The Hindu earlier.

The CMCHIS staff will first seek to orient hospitals on these standards before beginning the process of pre-accreditation, according to officials.

It is expected that at a certain point, accreditation for a hospital will become a pre-condition for empanelment in the government insurance scheme.

Existing hospitals that do not have accreditation will also be eased into the process, officials said.

United India Insurance, the insurance partner for the State government in this venture, seems equally enthused by this move.

Asha Nair, director and general manager, United India Insurance, said, “I would be very happy if this can be implemented. It means we are ensuring a minimum quality of service for all healthcare consumers across the board.”

The ideal would be to make it qualifying criteria for new hospitals that apply for empanelment.

Hospitals that have already been empanelled can be given time and a deadline to get accreditation, she said.

Draft Minimum Standards for Various Categories of Clinical Establishments

The Clinical Establishments (Registration and Regulation) Act, 2010 has been enacted by the Central Government to provide for registration and regulation of all clinical establishments in the country with a view to prescribing the minimum standards of facilities and services provided by them. The act has already taken effect in 4 States and all Union Territories since 1st March 2012 vide Gazette Notification dated 28th February 2012.

Keeping in view to implement the act across the country the National Council for Clinical Establishments under the Chairmanship of Director General of Health Services, Government of India in consultation with various stakeholders has prepared draft minimum standards for various categories of Clinical Establishments for implementation of the Clinical Establishments Act.

The comments, suggestions, objections, including deletions /additions if required in the draft documents are invited from public at large, including the stakeholders like hospitals and other clinical establishments, consumer groups etc.

The draft standards for various categories of clinical establishments is available and can be downloaded from the link below


The comments may kindly be sent to Dr. Anil Kumar, CMO(AK) Room No.506 ‘D’ Wing, 5th Floor, Nirman Bhawan, New Delhi-110018 at his email- id with in one month of publication of this Notice on the website. A copy of the same may also be endorsed to

The last date for sending the comments is 20/04/2014.

Financial Management for Non Finance Management Teams in Healthcare Industry

About the Program

This program is exclusively designed for Healthcare Industry covering various verticals like  Hospitals, Diagnostic Centres, Nursing Homes, Medical Centres, OP Clinics, Wellness Centres etc.

Program Objective

The program is designed and intended for Non-Finance Management Teams in Healthcare spaceThe program provides a practical guide to analyze financial data and understanding the implications of financial performance of business and various nuances of financial management.

Objectives of the Program

  •  Understand the financial implications of their functional decisions and put them at ease when financial language/data passes by them.
  •  Be more informed participants in internal discussion especially when financial and cost related data is discussed.
  •  Read their own firm’s and competitor financial statements and to do a basic analysis of its financial strengths and weakness

Program Coverage

Understanding Financial Statements and the underlying Concepts

  • Balance sheet
    • Meaning
    • BS Structure
    • Assets
    • Liabilities
  • Profit and Loss Account (P&L)
    • Meaning
    • P&L Mechanism
    • Different levels of profit
    • Relationship between P&L and BS
    • Profit & cash flow
  • Cash Flow Statement (CFS)
    • Structure
    • Operating cash flows
    • Investing cash flows
    • Financing cash flows

Financial Statement Analysis

  • Financial ratio analysis
    • Ratios for assessing short term liquidity
    • Ratios for assessing long term financial strength
    • Ratios for assessing efficiency
    • Ratios for assessing performance
    • Performance drivers


  • Cash flow analysis


Working Capital (WC) Management

  • Concept of WC
  • The WC or operating cycle
  • Estimation of WC needs
  • Financing WC
  • Cash management
  • Credit management
  • Financial implications of Inventory management

 Cost-Volume-Profit (CVP) Analysis

  • Cost classification
  • Cost allocation – apportionment and absorption
  • Cost-volume-profit relationship
  • Break-even analysis and the significance of break-even point
  • Using CVP for decision-making
  •  “Operating Leverage” and its significance

Capital Investment Analysis

  • Basic framework – capital investment process
  • Time value of money
  • Methods of appraising capital investment
    • Accounting rate of return
    • Payback period
    • Net present value
    • Internal rate of return

Who can participate?

The following members from various verticals of the Healthcare industry can participate:

  • Promoters , Directors
  • Sr.Management Teams, Sr.Operational Teams, Sr.Marketing Teams
  • Administrators, Sr. HR Managers, Sr. Finance & Accounts Managers, Sr.QA Teams
  • Sr. IT Managers, Purchase & Stores Teams

Registration Fee Details 

Course Fee Rs.10,000/- plus 12.36% Service Tax per participant.

The cheque/DD to be drawn in favour of “Value Added Corporate Services P Ltd” payable at Chennai. Full payment in advance. Fees once paid will not be refunded. However changes in nomination before commencement of programme permitted.

Click here for registration forms – Registration_Form_Finance-for-NonFinance

Feedback given by Participants of Earlier Programs

Please click here for feedback given by participants who attended the previous sessions of the Program.

Program Schedule

Workshop will be held at  Hotel NKMS Grand, 6-3-563/31/1, Off Taj Deccan Road, Erramanzil, Somajiguda, Hyderabad – 500 082 on the 21st & 22nd of March 2014 spread over 2 full days (9.30 am to 5.30 pm).   Please click here for Google map to the Venue

Click Here for Google Maps Link

For More Details Contact:

Sr.Manager –Business Development

Sr.Manager – Operations

Padma Sriramakrishnan
Manager – Customer Service



Ayush industry terms GCP guidelines as hotchpotch presentation of allopathy norms

The department of Ayush’s good clinical practice (GCP) guidelines has fallen short of industry expectations. The final gazette documented is seen to be brimming with faults and urgently needs clarification of details. Though industry experts and academicians were consulted, yet the government has failed to put in their valuable inputs, pointed out representatives across the industry.


According to DBA Narayana, leading scientist, “While the intention of the Ayush department to bring out a formal guideline is appreciated keeping away the science of trial designs and focus on ethics committee, informed consent and other aspects of products and documentation, the final notified format is a hotchpotch presentation. There are slip-ups in the final version which is creating considerable apprehension and confusion. Over 90 per cent of the Ayush units engaged in the production of Ayurveda, Unani, Siddha and Homoeopathy drugs, are small and medium units. Now this 114 page guideline is seen as a tough document to comprehend by them.”


“The contents have failed to sustain the actual essence of the guidelines and there is also an absence of legal clarity. Further, in the section on new proprietary medicines, which recognises alcohol+water preparations, details of data submission and pilot human studies, we see no connection between the guidelines and the annexure. This leaves a huge ambiguity and could be misused by the regulatory authority and may end up harassing the industry. There is no mention whether MBBS or BAMS doctors would conduct the human studies or who would head the Ethics Committee,” said Dr Narayana.


Voicing similar concerns, JSD Pani, president, Karnataka Indian Medicine Manufacturers Association (KIMMA) stated that “despite industry consultation the inputs put forward by experts were not considered. It is a copy-paste of the allopathy GCP norms. Ancient system of traditional medicine needs to be relevant to modern concepts. The current guidelines, are seen as a challenge to conduct clinical trials based on modern medicine systems”.


“There are apprehensions on how the Ayush industry could adhere to GCP guidelines. For instance, government had indicated that only 56 per cent of the 9,000 Ayurveda units have adhered to the Schedule T GMP norms, enforced a decade ago. In such a scenario GCP adherence would be difficult for the small-medium manufacturers. But, what could come in as a support is the Ayush Clusters model that has been commissioned in Kerala and Punjab and to be flagged off in Karnataka in a few months. The tiny small and medium industries located in the Cluster could be guided by experts for GCP adherence,” pointed out Pani.


In order to ensure total compliance, government should interact with industry, academia and researchers and the state regulatory officials.


“Frequent, intensive workshops and training programmes are needed to educate the industry about the new norms and help remove the fears on its implementation. Regulators too need to attend so that they can appreciate the issues and work positively to help industry comply with the guidelines.


It is a known fact that most Ayush regulators do lack experience in clinical trials unlike their counterparts in the DCGI office,” said Dr Narayana.


Appreciating the guideline as the an important document for the Ayush sector after the Schedule T norms, Dr Nagesh Sandu, head, technical committee, Ayurvedic Drug Manufacturers Association (ADMA) and director, Sandu Brothers(P) Ltd. stated that although the norms for clinical research are broad-based they are not specific to many aspects of human studies. “We need to see how this would be implemented in the wake of capacity gaps. The government will need to interact closely with the industry to ensure compliance to the norms.”


Source : Pharmabiz News dt May 13, 2013, 0800 IST



The department of Ayush has issued good clinical practice (GCP) guidelines.

The department of Ayush has issued good clinical practice (GCP) guidelines for clinical trials in Ayurveda, Siddha and Unani (ASU) medicines which will facilitate the researchers and institutions in adopting a standard way of good clinical practice while conducting the ASU clinical trials.


The guidelines are addressed to investigators and all those, who are interested, concerned, involved and affected with the conduct of clinical trials on ASU drugs. These are timely in view of the focus being given for scientific validation and for promoting evidence-based use of ASU treatments and are meant for voluntary use, not linked with any provisions of Drugs & Cosmetics (D&C) Act, 1940, and the rules thereunder.


The GCP is a set of guidelines which encompasses the design, conduct, termination, audit, analysis, reporting and documentation of the studies involving human subjects. The fundamental tenet of GCP is that in research on man, the interest of science and society should never take precedence over considerations related to the well being of the study subject.


It aims to ensure that the studies are scientifically and ethically sound and that the clinical properties of the ASU medicine under investigation are properly documented. The guidelines seek to establish two cardinal

principles: protection of the rights of human subjects and authenticity of ASU medicine clinical trial data generated.


The objective of this 114-page log document is to encourage that clinical studies in ASU systems are undertaken in accordance with ethical and scientific standards and safety aspects and rights of participants are protected. Adhering to methodical documentation of trials will help bringing credibility to the efforts of persons and institutions involved in the process, which otherwise was lacking for want of any ASU-specific guiding document.


The guidelines are significant as although the ASU systems are known for their long history of safe and effective use, yet validation of safety and efficacy using scientific and evidence-based methodologies is needed for the purpose of universal acceptability, gaining confidence of practitioners and satisfaction of end users in the products.


The arguments of having long standing in the medical practice or market are often unconvincing and there has been persistent and increasing demand of documented proof of clinical safety and efficacy of ASU medicine. In this perspective, the clinical trials in ASU systems need to be guided on the principle of ‘Good Clinical Practice’. Researchers, sponsors and drug manufacturers, therefore, have to be well versed with the standard scientific procedures that are required to be followed while conducting clinical trials with ASU interventions to achieve objective and reproducible results.


These guidelines are formulated based on CDSCO Document on GCP Guidelines

(2001) for Clinical Trials on Pharmaceutical Products. They should be followed for carrying out all ASU medicine research in India at all stages of drug development, whether prior or subsequent to product registration in India.


With the introduction of Drugs & Cosmetics Rule 158 B since August 2010, the requirement of proof of effectiveness for licensing of patent or proprietary ASU medicine has necessitated the development of present guidelines of Good Clinical Practice. However, these guidelines are for voluntary use by the researchers interested in taking up clinical trials by using ASU medicine.

Conducting clinical trials and generating evidence on the basis of these guidelines would help convincing the world about the potential scope of ASU remedies in scientific parlance and address the questions of lack of evidence and validation. Immense opportunities thus lie ahead for the stakeholders to adopt the guidelines as a tool for promoting scientific and quality clinical research for credible outcomes.


The guidelines fulfill a long felt need to guide the direction of clinical trials on ASU remedies and therapies.


Source : Pharmabiz News dt April 18, 2013, 0800 IST



Experts criticise CCIM's notification on minimum standards for ayurvedic colleges & attached hospitals

Experts criticise CCIM’s notification on minimum standards for ayurvedic colleges & attached hospitals
August 17, 2012, 0800 IST – Source : Pharmabiz News

The Central Council of Indian Medicine (CCIM)’s new gazette notification on minimum standards & requirement for ayurvedic colleges and attached hospitals have come in for severe criticisms from experts in the field of Ayurveda, Siddha and Unnai (ASU).

Expressing concern over the notification, experts stated that it is against the interest of the industry. Alarmed over the development, the
scholars from the Institute of Post Graduate Teaching & Research in Ayurveda (IPGT & RA), Gujarat Ayurved University, have urged the government to take immediate steps to withdraw the said notification and make required amendments in the same so that it does not effect the quality and reputation of the ayurvedic educational system in the country.

In the notification, the CCIM has lowered the minimum requirement of teaching faculty to just 30 teachers in an ayurvedic college with capacity of 50 seats which had been already reduced from 43 to 35 in the last gazette. Of these only 90 per cent i.e. 27 teachers are required to run the college, this will reduce the already existing jobs by 30 per cent. Industry fears that in this case no fresh post graduate will get the job even in the next 10 years leading to unemployment in the field restricting the entry of good students in the field in future.

Further they have increased the age for retirement in the colleges from 65 to 70 years which further reduces new job opportunities for the young students. To add to their woes, the student bed ratio has been reduced to 1:1 that means only 50 beds will be required in an ayurvedic college with an intake capacity of 50 students. Of these only 40 per cent average occupancy is must, that means at any point of time in an ayurvedic college only 24 IPD patients is essential for the 180 students (60 of 3rd year, 60 of 4th year and 60 internees).

“This will make students low in confidence and their clinical approach will be completely distorted. In departments like panchkarma, stri-prasuti tantra, shalya tantra and shalakya tantra only three to four patients will be admitted at a time and interns will not get enough patient to familiarise with each procedure of these subjects and we fear that it will severely hamper the clinical exposure to the student,” an expert pointed out.

Industry sources claim that the notification was prepared without doing requisite research on the requirements of the present educational system as per the necessary standards and was drafted to please only a certain section of the industry. IPGT&RA scholars accused that CCIM which is responsible to regulate the ayurvedic educational system in the country to be involved in many activities that are of questionable nature.

“Latest gazette notification exposes the lack of expertise and knowledge of the representatives of CCIM and raises question on the eligibility and credibility of its members. The current notification will only degrade the standards of the ayurvedic education system in the country which is already in a state of shambles. Thus rather than taking a more progressive approach that has a long term vision to attract new students
to this field of traditional science, CCIM is only pushing away the probable candidates interested in taking up the BAMS course with their reckless attitude,” the expert said.

Dept of Ayush to introduce Ayush-Nursing from July, 2012 in 20 Ayurvedic Colleges across country

Dept of Ayush to introduce Ayush-Nursing from July, 2012 in 20 Ayurvedic Colleges across country

March 30, 2012, 0800 IST – Source : Pharmabiz News

Aiming to provide proper quality care to the patients undergoing treatment under ayurvedic system of medicine, the department of Ayush in cooperation with School of Health Sciences, Indira Gandhi National Open University (IGNOU), Delhi will introduce a certificate course in Ayush-Nursing (Ayurveda) for Auxiliary Nurse Midwives (ANM)/ General Nursing & Midwifery (GNM) from July this year across country. IGNOU is also planning to begin certificate programmes in Unani and Homoeopathy in the coming years.

This programme is designed to discuss the current issues and trends in Ayurveda, to develop skills to provide nursing care to patients admitted to hospitals providing care through the ayurvedic systems of medicine, to develop understanding and depth in performing ayurvedic nursing skills and to apply knowledge of Ayurveda in diverse settings- hospital and community.

“As per government of India’s report on Human Resources for the health sector, there is no ANM trained nurses in Ayurveda. So the GOI along with IGNOU has decided to start this programme to provide certified quality professionals in this field. IGNOU with its large network has the capability of catering to the needs of a large number of aspirants,” said M Rajesh, regional director of IGNOU, Mumbai.

Prof. Bimla Kapoor, director of School of Health Sciences, IGNOU, Delhi said that this course will be conducted by IGNOU in 20 Ayurvedic Colleges throughout the country as identified by Department of Ayush as Programme Study Centres. “In our country we have around 20 centres which includes: Government Ayurveda College, Thiruvananthapuram, Govt Ayurveda College Mysore, RA Podar Medical College (AYU), Mumbai, Ayurvedic & Unani Tibbia College, New Delhi, Rajiv Gandhi Ayurvedic College, Paprola, J B Roy Govt Ayurvedic College, West Bengal, SDM Ayurvedic College, Udupi, Govt. Ayurveda College, Nagpur, etc.. which have intake capacity to admit 30 students having ANM/GNM qualification and already in service,” she added.

Prof. Kapoor added that GoI has mentioned that the required centres should have 30 candidates in service for ANM/GNM in Ayurveda Hospitals across the country for training at the Ayurveda colleges. Although this course is designed for all ANM/GNMs even then preference for the first year may be given to ANM/GNM employed in Ayurveda Hospitals in the states. In case of non-availability of ANM/GNM in the Ayurveda Hospitals then the interested ANM/GNM candidate in the allopathic hospitals can be nominated to go for training in this course.

The minimum duration of the programme is for 6 months and the maximum duration is for two years, and also the students will be given hands on training by the existing Ayurveda faculty in identified centres.